ECM
KERX

Endurant Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Endurant Capital Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-142,100
Closed -$875K – 109
2017
Q1 		$875K Buy
+142,100
New +$875K 0.28% 69
2016
Q4 		– Sell
-116,000
Closed -$616K – 104
2016
Q3 		$616K Buy
+116,000
New +$616K 0.23% 71